MILabs News & Updates
Stay up to date with the latest developments from MILabs and the research community we support. Here you will find company news, product updates, scientific milestones, and insights into how researchers are using MILabs imaging solutions to advance their work.
MILabs and Mid-Atlantic Imaging Services announce strategic support agreement for the US and Canada
MILabs, B.V. the Netherlands-based innovator and manufacturer of pre-clinical SPECT/PET/CT imaging devices used in biological and pharmaceutical research today announces a strategic service and support agreement with Mid-Atlantic Imaging Services of Columbia, MD. As part of MILabs growth and expansion plans for the Americas market, Mid-Atlantic Imaging Services will partner with MILabs to provide installation and first response service support to MILabs customers in the US and Canada.
Frost & Sullivan Product Innovation Award for VECTor
The Frost & Sullivan Best Practices team has presented MILabs with the 2010 New Product Innovation Award for VECTor. In their analysis MILabs is recognized as a rapidly growing company standing out among the players in the Preclinical Imaging market with world-class products. MILabs’ proprietary VECTor technology provides fully integrated simultaneous SPECT and PET imaging with sub-mm resolution. In numerous molecular imaging applications VECTor surpasses the resolution capabilities of both classical coincidence PET and competing SPECT technologies.
Press release: TU Delft and MILabs merge PET and SPECT biomedical imaging techniques
TU Delft and MILabs merge PET and SPECT biomedical imaging techniques and deliver increased resolution
TU Delft and Molecular Imaging Labs (MILabs) have succeeded in combining two forms of medical imaging techniques into one piece of equipment. These techniques are particularly useful for cancer research. The two techniques are known as microPET and microSPECT. SPECT and PET can be performed simultaneously and they give a higher resolution than traditional microSPECT and microPET. The new device is known as the VECTor (Versatile Emission Computed Tomography) and is designed for use in fundamental research into the functioning of cells and organs. It can show functional details smaller than half a millimetre.
Study shows: SPECT and PET are useful in imaging IGF-1R
Dutch researchers using preclinical imagers U-SPECT from MILabs of Utrecht, The Netherlands, and Inveon PET from Siemens Healthcare of Knoxville TN, said the imaging methods allowed them to successfully and noninvasively visualize the insulinlike growth factor 1 receptor among animal subjects with triple-negative breast cancer. Being able to image the receptor could improve patient selection from the triple-negative breast cancer patient population for targeted treatment using IGF-1R antibodies, an expert said.
For more information see the Full article at AuntMinnie.com (free registration)
Interview in Next Generation Pharmaceutical
NGP gathers industry experts of Cisbio, MILabs, PerkinElmer and Roche to discuss the current drug development space. Prof. Beekman, CEO/CSO Milabs states that drug development can, and needs to become, much faster and effective by using novel tools that facilitate early selection of potentially successful drug leaLink to full article
No results found.